Symbiotix Biotherapies, Inc. Employee Directory

Biotechnology ResearchMassachusetts, United States2-10 Employees

Symbiotix Biotherapies, Inc. is a biotechnology research company based in Boston, Massachusetts. It is developing a novel class of therapies that regulate regulatory T cells using molecules derived from the human microbiome, delivered as oral agents. These therapies target inflammatory bowel disease, multiple sclerosis, and other immune-mediated diseases.

The company traces its research to more than two decades of work at Harvard Medical School/Brigham & Women’s Hospital, California Institute of Technology, and Dartmouth College. In 2018 it announced a process development and manufacturing agreement with Paragon Bioservices. The organization is small and operates within the biotechnology research sector, pursuing microbiome-based therapeutic approaches.

Sign up for free to view info

Company overview Email format